[HTML][HTML] Polycystic ovary syndrome: etiology, current management, and future therapeutics

S Singh, N Pal, S Shubham, DK Sarma… - Journal of Clinical …, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically
characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries …

[HTML][HTML] Inositols: from established knowledge to novel approaches

S Dinicola, V Unfer, F Facchinetti, CO Soulage… - International Journal of …, 2021 - mdpi.com
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in
many biological pathways. Since the discovery of their involvement in endocrine signal …

[HTML][HTML] Glucagon-like peptide-1: A multi-faceted anti-inflammatory agent

SF Mehdi, S Pusapati, MS Anwar, D Lohana… - Frontiers in …, 2023 - frontiersin.org
Inflammation contributes to many chronic conditions. It is often associated with circulating
pro-inflammatory cytokines and immune cells. GLP-1 levels correlate with disease severity …

[HTML][HTML] Immune regulation in polycystic ovary syndrome

Y Luan, L Zhang, Y Peng, Y Li, R Liu, C Yin - Clinica chimica acta, 2022 - Elsevier
A polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting
females. Furthermore, it is a heterogeneous disease with a variety of etiologies and …

Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment

C Xing, J Zhang, H Zhao, B He - International Journal of Women's …, 2022 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases causing
infertility in women of childbearing age. It is characterized by hyperandrogenemia (HA) …

[HTML][HTML] Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease

C Guan, S Zahid, AS Minhas, P Ouyang, A Vaught… - Fertility and sterility, 2022 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women
of reproductive age and is hallmarked by hyperandrogenism, oligo-ovulation, and polycystic …

[HTML][HTML] Improvement effect of metformin on female and male reproduction in endocrine pathologies and its mechanisms

AO Shpakov - Pharmaceuticals, 2021 - mdpi.com
Metformin (MF), a first-line drug to treat type 2 diabetes mellitus (T2DM), alone and in
combination with other drugs, restores the ovarian function in women with polycystic ovary …

[HTML][HTML] Polycystic ovary syndrome: a brain disorder characterized by eating problems originating during puberty and adolescence

RPM Steegers-Theunissen, RE Wiegel… - International journal of …, 2020 - mdpi.com
Polycystic ovary syndrome (PCOS) is an endocrine condition associated with reproductive
and psychiatric disorders, and with obesity. Eating disorders, such as bulimia and recurrent …

[HTML][HTML] Molecular mechanisms of laparoscopic ovarian drilling and its therapeutic effects in polycystic ovary syndrome

KM Seow, YW Chang, KH Chen, CC Juan… - International Journal of …, 2020 - mdpi.com
Polycystic ovary syndrome (PCOS) is a common endocrinopathy, characterized by chronic
anovulation, hyperandrogenism, and multiple small subcapsular cystic follicles in the ovary …

An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options

H Islam, J Masud, YN Islam, FKM Haque - Women's Health, 2022 - journals.sagepub.com
Polycystic ovary syndrome is the most common endocrine disorder in women of
reproductive age, which is still incurable. However, the symptoms can be successfully …